Latest News
-
Indian Railway Finance Corp (IRFC): Top NBFC Railway Stock Advised To BUY; Short-To-Long Term Target Prices -
2 Multibagger Defence To Shield Your Money, Buy On April 24; Prabhudas Sets Target Prices, Stop Loss -
Rs 3.5/Share Dividend Declared: NBFC Declares 55.5% YoY Surge In PAT, Shares Up 87% In 1-Yr -
Rs 118/Share Dividend: Healthcare Stock Below Rs 400 Turned Ex-Dividend, Payout Soon; Buy For Rs 515 Target -
6,693% Returns: Below Rs 75, Pharma Penny Stock Ex-Dividend For Rs 40/Sh Payout After 9 Years; Do You Own? -
TCS Vs Infosys Vs Wipro Shares, ADRs, Upcoming Dividends: Which Mega IT Stocks To Buy After Q4 Results? -
SBI Card Launches 3 New Variants of Its Travel Credit Card ‘SBI Card MILES’ -
25% Dividend Record Date: Logistic Stock Nears 1-Year High And It Belongs To Mahindra; Motilal Neutral -
1:10 Split, 26 Dividends: Tata's 26-Year-Old Retail Stock In Focus, Q4, Dividend Ahead; Buy For Target Rs 4200 -
1:5 Split Soon: Rs 2,300 Defence Stock To Split Into Five Shares, Rs 400 Cr Fundraising Too; Hits 52-Week High
Divi's Labs Reports 31% Rise In Net Profit At Rs 471 Crore
On Saturday, Divi's Laboratories reported a 31.05% increase in its net profit at Rs 470.62 crore for the December-ended quarter, on the back of robust sales. In the same period of the corresponding year, the company posted a net profit of Rs 359.09 crore.
In a BSE filing, Divi's Laboratories said that the total income of the company on a consolidated basis stood at Rs 1,720.76 crore for the quarter under consideration.
It was Rs 1,437.93 crore for the same period a year ago, it added.
The company has been able to have normalised operations during the quarter, Divi's Laboratories said.
The Operating profit or earnings before interest, tax, depreciation and amortisation for the Hyderabad-based company rose 45% from the previous year to Rs 688.7 crore. Margins expanded 640 basis points to 40.5% from 34.1% last year.
In December last year, Divi's Laboratories became only the second listed pharma company in India to cross the Rs 1 lakh crore market cap.
Shares of the pharma company closed 4.73% higher at Rs 3,853 on NSE on Friday.
